Bellicum Pharmaceuticals Presents Encouraging Preclinical Data for GoCAR-NK Cell Program at Society for Immunotherapy of Cancer Annual Meeting Nia JulianNovember 8, 2019 Facebook0 Twitter Pinterest0 0 Likes